Reported September 03, 2009
PARIS — Governments bracing for a second, possibly more lethal, wave
of swine flu are all grappling with the same unforgiving dilemma: with not
enough vaccine to go around, who is going to get jabbed first?
Any lingering hopes that pharmaceutical companies could rapidly fill orders
for more than a billion doses from northern hemisphere countries alone were
quashed this week by the World Health Organisation (WHO).
"We need to gather advice on priority groups for initial protection," WHO
head Margaret Chan said Friday.
"This is one of the most difficult decisions governments around the world
will need to make, especially as we know that supplies will be extremely
limited for some months to come."
But national leaders looking for guidance from international health
authorities on how to best distribute vaccines that will not be available in
most cases before early October, at best, are bound to be disappointed.
The European Union has yet to issue any guidelines specific to the new
strain of A(H1N1) influenza that has swept across the globe, infecting
hundreds of thousands and claiming at least 1,800 lives.
The WHO does suggest that health care workers should be given priority, a
policy embraced by most states, but stops short of making further
recommendations.
"Individual countries have to look at their own conditions and adapt," WHO
spokesman Melinda Henry told AFP from Geneva.
"They have to decide whether they want to stop transmission, protect
essential infrastructure, or reduce illness and death."
The problem is that these strategies each target a different segment of
society, which means -- in a context of shortage -- that there simply won't
be enough vaccine to protect everyone during the first critical months.
And that's not all: there is also disagreement among epidemiologists, who
study how infections spread, as to which approach would save the most lives.
Researchers writing this week in the journal Science argue that the best way
to halt the spread of the virus for pandemic flu is to vaccinate school age
children and their parents first.
The study makes projections for the United States, but the model could be
applicable in other developed nations, and perhaps across the board.
In Japan, the systematic vaccination of school children prevented more than
40,000 deaths across all age groups every year from the 1960s until the
policy was dropped in 1994, according to an earlier study in the New England
Journal of Medicine.
This strategy, however, is sharply at odds not only with the one adopted by
most countries for fighting seasonal flu, but the one taking shape for the
2009 pandemic as well: prioritising what have long been identified as
high-risk groups.
These usually include very young children older than six months, pregnant
women, persons with chronic lung conditions, and the very elderly.
But pandemics don't behave like seasonal flu outbreaks, and don't always
attack the same targets, experts say.
"The shift in mortality toward younger age groups was the most striking
characteristic of the 20th-century pandemics," notes Mark Miller, a
researcher at the Fogarty International Center, part of the US National
Institutes of Health.
Early indications suggest the current pandemic -- while far less deadly than
earlier ones, at least so far -- fits this pattern.
"With this virus the severe outcomes happen to people between 20 and 50 a
lot of the time, which is very uncharacteristic of (seasonal) influenza,"
said Lone Simonsen, an epidemiologist at George Washington University and
one of the architects of the US Influenza Genome Sequencing Project.
"There are some unusual risk factors too, such as severe obesity," she told
AFP. Pregnant women seem to be at greater risk in all cases, she added.
And data from Mexico, the epicentre of the pandemic, shows that persons born
before 1957 seems to have in-built immunity to the new strain, which could
mean that the elderly, as a group, are less rather than more vulnerable.
Even tallying up potential lives lost is not a straight-forward process.
Are the deaths of a small child and a septuagenarian simply two lives lost,
or does the child's weigh more heavily because of the greater number of
"life years lost"?
"Which strategy countries choose is ultimately a political and ethical
decision," the European Centre for Disease Prevention and Control said in a
statement last year, before the current pandemic struck.
Source : AFP